ESC 365 - New onset atrial fibrillation: which drug to choose for cardioversion.

ESC Premium Access

New onset atrial fibrillation: which drug to choose for cardioversion.

Session: Atrial fibrillation

Topic: Drug therapy

Speaker: Doctor J. Poess (Leipzig, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Janine Poess

Heart Center of Leipzig, Leipzig (Germany)

18 presentations

6 followers

7 more presentations in this session

Gastrointestinal bleeding in an atrial fibrillation patient

Speaker: Doctor T. Hall (Oslo, NO)

Gastrointestinal bleeding in an atrial fibrillation patient - What do the Guidelines say?

Speaker: Professor B. Popescu (Bucharest, RO)

Gastrointestinal bleeding in an atrial fibrillation patient. How to implement the Guidelines – Panel discussion

Gastrointestinal bleeding in an atrial fibrillation patient - Conclusion and take home message.

Speaker: Professor C. Torp-Pedersen (Hilleroed, DK)

New onset atrial fibrillation: which drug to choose for cardioversion - What do the Guidelines say?

Speaker: Professor J. Steffel (Zurich, CH)

Access the full session

Atrial fibrillation

Speakers: Doctor J. Poess, Doctor T. Hall, Professor B. Popescu, Professor C. Torp-Pedersen, Professor J. Steffel

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources